Orthopedic and general surgery medtech company Conmed reported $152.3 million in orthopedic surgery sales during the second quarter of 2026, according to a July 29 news release from the company.
Here are five things to know:
- Conmed’s total net sales in the second quarter were $343.5 million, and the company has recorded $660.5 million in total net sales so far in 2026.
- Orthopedic surgery sales increased more than 8% in the second quarter of 2026, up from $140.7 million in the second quarter of 2025.
- So far in 2026, Conmed has recorded $300 million in orthopedic surgery sales, an increase of 7.5% over the first half of 2025.
- Conmed’s net income was $23.1 million in the second quarter of 2026, and $36.9 million year to date.
- The company is projecting total net sales for 2026 to be between $1.36 billion and $1.37 billion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.